AIM ImmunoTech Inc. [AIM] saw a change by 14.29% with the Thursday trading session, closing the trade at the price of $1.20. The company is holding 8.04M shares with keeping 7.71M floating shares. With the latest trading session, the stock is set at 214.96% off compared to its 52-week low, sliding -91.90% from high for the same period of time.
Since its 90-day high, the share price saw a move by -25.00%, trading +209.52% in oppose to its 90-day low While during the day, 8.04M shares valued at 7.02 million were bought and sold.
AIM ImmunoTech Inc. [NYSE:AIM]: Analyst Rating and Earnings
Its stock price has been found in the range of 0.38 to 14.81. This is compared to its latest closing price of $1.05.
Fundamental Analysis of AIM ImmunoTech Inc. [AIM]
Now let’s turn to look at profitability: with a current Operating Margin for AIM ImmunoTech Inc. [AIM] sitting at -3121.25 and its Gross Margin at -266.08.
This company’s Return on Total Capital is -105.88, and its Return on Invested Capital has reached -99.30%. Its Return on Equity is -141.43, and its Return on Assets is -28.72. These metrics suggest that this AIM ImmunoTech Inc. does a poor job of managing its assets, and likely won’t be able to provide successful business outcomes for its investors in the near term.
Turning to investigate this organization’s capital structure, AIM ImmunoTech Inc. [AIM] has generated a Total Debt to Total Equity ratio of 114.51. Similarly, its Total Debt to Total Capital is 53.38, while its Total Debt to Total Assets stands at 10.95. Looking toward the future, this publicly-traded company’s Long-Term Debt to Equity is -22.82, and its Long-Term Debt to Total Capital is 44.80.
What about valuation? This company’s Enterprise Value to EBITDA is -1.17. The Enterprise Value to Sales for this firm is now 37.44, and its Total Debt to Enterprise Value stands at 0.49. AIM ImmunoTech Inc. [AIM] has a Price to Book Ratio of 1.70.
Shifting the focus to workforce efficiency, AIM ImmunoTech Inc. [AIM] earns $11,121 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 0.66 and its Total Asset Turnover is 0.01. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 0.72 and its Current Ratio is 0.72. This company is not investing its short-term assets in an optimally efficient way, making it a riskier investment.
AIM ImmunoTech Inc. [AIM] has 8.04M shares outstanding, amounting to a total market cap of $9.65M. Its stock price has been found in the range of 0.38 to 14.81. At its current price, it has moved down by -91.90% from its 52-week high, and it has moved up 214.96% from its 52-week low.
This stock’s Beta value is currently 0.72, which indicates that it is 10.53% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 60.25. This RSI score is good, suggesting this stock is neither overbought or oversold.
Conclusion: Is AIM ImmunoTech Inc. [AIM] a Reliable Buy?
AIM ImmunoTech Inc. [AIM] stock is presenting a less attractive investment opportunity when compared to similarly-sized corporations in the same industry. The price performance of these shares has not shown much promise, and the financial results that this company has recently delivered present a highly risky investment.